Evaluating Real-World National and Regional Trends in Definitive Closure in U.S. Burn Care: A Survey of U.S. Burn Centers.

Publication Year: 2022

DOI:
10.1093/jbcr/irab151

PMCID:
PMC8737084

PMID:
34329478

Journal Information

Full Title: J Burn Care Res

Abbreviation: J Burn Care Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Traumatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest and Source of Funding: This study was sponsored by Avita Medical, Valencia, CA. IQVIA received funding from Avita Medical to assist with survey development, data analyses, and manuscript preparation. C.P.F., S.K., and P.V. are employees of IQVIA, Inc., which provides consulting and other research services to biopharmaceutical companies. J.S. and T.W. are employees and shareholders of Avita Medical. J.E.C. is a consultant with SpectralMD, Inc. and Avita Medical, Ltd. Considering the association with Avita Medical, in lieu of compensation, donations are made to a local 501(c)(3) charity supporting local burn prevention, outreach, education, and survivor programs. J.E.C. is a stockholder of Permeaderm Inc. and SpectralMD Inc. and has research supported by Spirit of Charity Foundation Burn Research Fund. H.A. is a consultant for Avita Medical and has received honoraria for consulting services. D.C., J.A.G., S.J. have no conflicts to declare. K.N.F. is the PI for research on studies sponsored by the American Burn Association (ABRUPT), Atox-Bio, BARDA, Polynovo Biomaterials, Mallinckrodt, and Mediwound and is a consultant and former PI for Baxter. K.N.F. is a consultant for Integra. W.L.H. is a consultant with Avita Medical, Vericel, and Avadim Health, Inc. and is a stockholder of PermeaDerm. J.H.H. disclosures include equity positions in Abbott Labs, AbbVie, Change Healthcare, and Imbed Biosciences and is a consultant for Mallinckrodt and Avita Medical. A.K. is an advisor to Avita Medical. N.K. is a consultant with Integra and an advisor for Avita Medical. J.S.L. has received honoraria for consulting services provided to Avita and PolarityTE. A.S. is an advisor for Avita Medical and Exsurco. J.W.S. provides consulting for Avita Medical, Kerecis, and Integra. Commercial Grants/Contracts paid to Institution (NOT individual) for research by Avita Medical, Kerecis, Aceso, Mallinckrodt Pharmaceuticals, MediWound, and SpectralMD. R.S. is an advisor to Avita Medical, Smith and Nephew, and Vericel."

Evidence found in paper:

"Conflict of Interest and Source of Funding: This study was sponsored by Avita Medical, Valencia, CA. IQVIA received funding from Avita Medical to assist with survey development, data analyses, and manuscript preparation. C.P.F., S.K., and P.V. are employees of IQVIA, Inc., which provides consulting and other research services to biopharmaceutical companies. J.S. and T.W. are employees and shareholders of Avita Medical. J.E.C. is a consultant with SpectralMD, Inc. and Avita Medical, Ltd. Considering the association with Avita Medical, in lieu of compensation, donations are made to a local 501(c)(3) charity supporting local burn prevention, outreach, education, and survivor programs. J.E.C. is a stockholder of Permeaderm Inc. and SpectralMD Inc. and has research supported by Spirit of Charity Foundation Burn Research Fund. H.A. is a consultant for Avita Medical and has received honoraria for consulting services. D.C., J.A.G., S.J. have no conflicts to declare. K.N.F. is the PI for research on studies sponsored by the American Burn Association (ABRUPT), Atox-Bio, BARDA, Polynovo Biomaterials, Mallinckrodt, and Mediwound and is a consultant and former PI for Baxter. K.N.F. is a consultant for Integra. W.L.H. is a consultant with Avita Medical, Vericel, and Avadim Health, Inc. and is a stockholder of PermeaDerm. J.H.H. disclosures include equity positions in Abbott Labs, AbbVie, Change Healthcare, and Imbed Biosciences and is a consultant for Mallinckrodt and Avita Medical. A.K. is an advisor to Avita Medical. N.K. is a consultant with Integra and an advisor for Avita Medical. J.S.L. has received honoraria for consulting services provided to Avita and PolarityTE. A.S. is an advisor for Avita Medical and Exsurco. J.W.S. provides consulting for Avita Medical, Kerecis, and Integra. Commercial Grants/Contracts paid to Institution (NOT individual) for research by Avita Medical, Kerecis, Aceso, Mallinckrodt Pharmaceuticals, MediWound, and SpectralMD. R.S. is an advisor to Avita Medical, Smith and Nephew, and Vericel."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025